Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval

Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval

Source: 
BioSpace
snippet: 

The FDA has approved Pfizer’s nasal spray, zavegepant, now to be marketed as Zavzpret, for the acute treatment of migraine in adults, the company announced Friday.